Free Trial
NASDAQ:CLOV

Clover Health Investments (CLOV) Stock Price, News & Analysis

Clover Health Investments logo
$3.19 -0.04 (-1.24%)
(As of 10:28 AM ET)

About Clover Health Investments Stock (NASDAQ:CLOV)

Key Stats

Today's Range
$3.19
$3.28
50-Day Range
$3.00
$4.35
52-Week Range
$0.61
$4.71
Volume
879,513 shs
Average Volume
7.71 million shs
Market Capitalization
$1.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Moderate Buy

Company Overview

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Clover Health Investments Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
65th Percentile Overall Score

CLOV MarketRank™: 

Clover Health Investments scored higher than 65% of companies evaluated by MarketBeat, and ranked 368th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Clover Health Investments has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Clover Health Investments has only been the subject of 2 research reports in the past 90 days.

  • Read more about Clover Health Investments' stock forecast and price target.
  • Earnings Growth

    Earnings for Clover Health Investments are expected to grow in the coming year, from ($0.12) to ($0.07) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Clover Health Investments is -16.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Clover Health Investments is -16.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Clover Health Investments has a P/B Ratio of 5.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.05% of the outstanding shares of Clover Health Investments have been sold short.
  • Short Interest Ratio / Days to Cover

    Clover Health Investments has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Clover Health Investments has recently decreased by 7.06%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Clover Health Investments does not currently pay a dividend.

  • Dividend Growth

    Clover Health Investments does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.05% of the outstanding shares of Clover Health Investments have been sold short.
  • Short Interest Ratio / Days to Cover

    Clover Health Investments has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Clover Health Investments has recently decreased by 7.06%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Clover Health Investments has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Clover Health Investments this week, compared to 4 articles on an average week.
  • Search Interest

    Only 23 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -12% compared to the previous 30 days.
  • MarketBeat Follows

    15 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is an increase of 114% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Clover Health Investments insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.28% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.77% of the stock of Clover Health Investments is held by institutions.

  • Read more about Clover Health Investments' insider trading history.
Receive CLOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.

CLOV Stock News Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Clover Health Investments Corp - Class A
See More Headlines

CLOV Stock Analysis - Frequently Asked Questions

Clover Health Investments' stock was trading at $0.9521 at the beginning of 2024. Since then, CLOV shares have increased by 239.3% and is now trading at $3.23.
View the best growth stocks for 2024 here
.

Clover Health Investments, Corp. (NASDAQ:CLOV) released its earnings results on Wednesday, November, 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.01. The company earned $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative trailing twelve-month return on equity of 25.46%.

Top institutional investors of Clover Health Investments include Geode Capital Management LLC (0.97%), PNC Financial Services Group Inc. (0.97%), Charles Schwab Investment Management Inc. (0.60%) and State Street Corp (0.44%). Insiders that own company stock include Anna U Loengard and Chelsea Clinton.
View institutional ownership trends
.

Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Zomedica (ZOM), AMC Entertainment (AMC), SoFi Technologies (SOFI), Jumia Technologies (JMIA), NIO (NIO), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/06/2024
Today
12/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
Insurance
Current Symbol
NASDAQ:CLOV
Fax
N/A
Employees
552
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$6.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+54.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-213,360,000.00
Pretax Margin
-6.21%

Debt

Sales & Book Value

Annual Sales
$2.12 billion
Book Value
$0.59 per share

Miscellaneous

Free Float
389,462,000
Market Cap
$1.62 billion
Optionable
Optionable
Beta
1.94
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CLOV) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners